Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment

Ibis, KAMURAN; Saglam, Sezer; Saglam, Esra; Firat, Pinar; Yilmazbayhan, Dilek; Toker, Alper; Ozkan, BERKER; Hancer, Veysel; BUYUKDOGAN, Murat; Disci, Rian; Pilanci, Kezban

doi:10.1016/j.prp.2018.07.010

Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment

Ibis K., Saglam S., Saglam E. K., Firat P., Yilmazbayhan D., Toker A., ...More

PATHOLOGY RESEARCH AND PRACTICE, vol.214, no.9, pp.1291-1296, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 214 Issue: 9
Publication Date: 2018
Doi Number: 10.1016/j.prp.2018.07.010
Journal Name: PATHOLOGY RESEARCH AND PRACTICE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1291-1296
Keywords: Non-small cell lung cancer (NSCLC), Carbonic anhydrase IX (CA DC), Neoadjuvant treatment, Prognosis, Overall survival, Disease free survival, POOR-PROGNOSIS, GENE-EXPRESSION, CA-IX, HYPOXIA, RADIOTHERAPY, CARCINOMA, PLASMA
Istanbul University Affiliated: Yes

Abstract

Background: To assess the prognostic importance of carbonic anhydrase IX (CA IX), a hypoxic biomarker, after neoadjuvant treatment in Stage III non-small cell lung cancer (NSCLC) patients.